Literature DB >> 12902586

Syphilis prevalence has rapidly decreased in South Korea.

Y-H Cho1, H O Kim, J-B Lee, M-G Lee.   

Abstract

OBJECTIVES: To determine the current prevalence of syphilis in the general population of South Korea and its trend over the past 20 years.
METHODS: 15,402 adults, who all were aged over 20 (6888 blood donors, 4951 physical examinees, and 3563 pregnant women) were examined from January 1999 to December 2000. All subjects were screened using a VDRL test, and positive results were confirmed by a FTA-ABS test. The prevalence was compared with the results of previous surveys in similar population groups performed by same authors.
RESULTS: The prevalence of syphilis in South Korea was found to be 0.2%. Although has been consistent decreasing trend since 1977 (p<0.0001), there is no statistical difference between 1995 and 2000 (p=0.6992).
CONCLUSIONS: The prevalence of syphilis has decreased significantly since 1977. However, it has not reduced much since 1995, and it seems that the prevalence has reached a plateau. Until now, not all syphilis patients were registered and followed up by the public health centres because there were so many syphilis patients. However, as this survey shows, the number of syphilis patients has reduced a great deal and it is believed that a more thorough management strategy including all newly diagnosed patients is necessary in order to further reduce the prevalence of syphilis in South Korea.

Entities:  

Mesh:

Year:  2003        PMID: 12902586      PMCID: PMC1744720          DOI: 10.1136/sti.79.4.323

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  9 in total

Review 1.  Epidemiology and management of infectious diseases in international adoptees.

Authors:  Thomas S Murray; M Elizabeth Groth; Carol Weitzman; Michael Cappello
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

2.  Evaluation of a Rapid Immunochromatographic Treponemal Antibody Test Comparing the Treponema Pallidum Particle Agglutination Assay.

Authors:  Jong-Han Lee; Chae Seung Lim; Min-Geol Lee; Hyon-Suk Kim
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

3.  The degree of safety of family replacement donors versus voluntary non-remunerated donors in an Egyptian population: a comparative study.

Authors:  Ibrahim Y Abdel Messih; Mona A Ismail; Abeer A Saad; Mary R Azer
Journal:  Blood Transfus       Date:  2012-11-20       Impact factor: 3.443

4.  A case of primary syphilis in the rectum.

Authors:  Sung Ho Song; Ick Jang; Bum Sik Kim; Eun Tak Kim; Seung-Hyo Woo; Mee Ja Park; Chang Nam Kim
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

5.  Sexually transmitted infections in Pakistan.

Authors:  Muhammad Arif Maan; Fatma Hussain; Javed Iqbal; Shahid Javed Akhtar
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

6.  Comparison of an automated rapid plasma reagin (RPR) test with the conventional RPR card test in syphilis testing.

Authors:  Jong-Han Lee; Chae Seung Lim; Min-Geol Lee; Hyon-Suk Kim
Journal:  BMJ Open       Date:  2014-12-31       Impact factor: 2.692

7.  Comparison of automated treponemal and nontreponemal test algorithms as first-line syphilis screening assays.

Authors:  Hee Jin Huh; Jae Woo Chung; Seong Yeon Park; Seok Lae Chae
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464

8.  TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates: efficacy study in a single institute in Korea.

Authors:  Mi Hae Chung; Chan Ok Shin; Juyoung Lee
Journal:  Korean J Pediatr       Date:  2018-04-23

9.  Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study.

Authors:  N Saman Wijesooriya; Roger W Rochat; Mary L Kamb; Prasad Turlapati; Marleen Temmerman; Nathalie Broutet; Lori M Newman
Journal:  Lancet Glob Health       Date:  2016-08       Impact factor: 26.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.